SeaStar Medical Holding (ICU) Share-based Compensation (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Share-based Compensation came in at $158894.0 in Q2 2026, down 99.97% on a YoY basis from $570.5 million in Q2 2025, and down 2.9% quarter-over-quarter from $163632.0 in Q1 2026.
Powered by 
Analysis
SeaStar Medical Holding (ICU) Share-based Compensation (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has reported Share-based Compensation for 6 consecutive years, with $158894.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation fell 99.97% year-over-year to $158894.0; the trailing twelve-month figure through Jun 2026 stood at $158894.0 (down 99.97% YoY), and the FY2025 full-year result was $624000.0, down 29.65% from the prior year.
- Share-based Compensation eased to $158894.0 in Q2 2026 per ICU's latest filing, from $163632.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $570.5 million in Q2 2025 and bottomed at $4000.0 in Q1 2022.
- Historically, Share-based Compensation has averaged $51.4 million across 5 years, with a median of $317500.0 in 2022.
- The sharpest annual moves came in 2025 and 2026: Share-based Compensation surged 1391258.54% in 2025, then plunged 99.97% in 2026.
- Over 5 years, Share-based Compensation stood at $605000.0 in 2022, then plunged by 36.2% to $386000.0 in 2023, then sank by 45.08% to $212000.0 in 2024, then sank by 66.98% to $70000.0 in 2025, then surged by 126.99% to $158894.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $158894.0, $163632.0, and $70000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 12.80 Mn |
| 10 | SeaStar Medical Holding | 12.74 Mn | 5.74 Mn | 561,000.00 | 158,894.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 158,894.00 |
| Mar 31, 2026 | 163,632.00 |
| Dec 31, 2025 | 70,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Jun 30, 2025 | 570.46 Mn |
| Mar 31, 2025 | 212,083.00 |
| Dec 31, 2024 | 212,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 351.03 Mn |
| Dec 31, 2023 | 386,000.00 |
| Sep 30, 2023 | 484,000.00 |
| Jun 30, 2023 | 555,000.00 |
| Mar 31, 2023 | 505,000.00 |
| Dec 31, 2022 | 605,000.00 |
| Sep 30, 2022 | 357,000.00 |
| Jun 30, 2022 | 345,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 287,382.00 |